Skip to content

Comparison of bilateral and bilateral with tri-segmental endoscopic drainage for high-grade malignant hilar biliary obstructions

Bilateral verses bilateral with tri-segmental endoscopic drainage using metal stents for high-grade malignant hilar biliary obstructions: a multicenter, randomized controlled trial: BRAVE study - BRAVE study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062220038
Enrollment
76
Registered
2022-06-23
Start date
2022-08-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-grade malignant hilar biliary obstructions High grade malignant hilar biliary obstructions, Bilataral drainage

Interventions

Two SEMS (Self Expandable Metallic Stent) group Three SEMS (Self Expandable Metallic Stent) group

Sponsors

Matsumoto Kazuyuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Unresectable malignant hilar biliary obstructions with Bismuth type IIIa or IV 2. Age over 18 3. Patient with fully informed consent

Exclusion criteria

Exclusion criteria: 1. Reconstructed bowel other than Billroth 1 2. Inferior border of the biliary stricture extends close to the duodenal papilla which required stenting across the papilla Vater. 3. Endoscopic drainage will be ineffective due to severely divided bile duct, or severe portal vein invasion due to multiple liver metastasis. . 4. Radical resection, radiation therapy, and proton/particle therapy will be planned 5. Patient with pregnant or possibly pregnant. 6. Patient who are not expected to live 1 month or longer 7. Patient judged by the investigator to be inappropriate to enroll.

Design outcomes

Primary

MeasureTime frame
non-recurrent biliary obstruction (non-RBO) rate

Secondary

MeasureTime frame
Technical Success, Clinical Success, Time to RBO, Cause of RBO, Complications other than RBO, Duration of procedure, Time to RBO by EST, Overall Survival, Technical Success and Clinical Success at Re-intervention

Contacts

Public ContactMatsumoto Kazuyuki

Okayama University Hospital

matsumoto.k@okayama-u.ac.jp+81-862357219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026